Should drug companies profit from coronavirus vaccine?
Clip: 09/17/2020 | 10m 21s Video has closed captioning.
COVID-19 vaccine development continues to be the subject of political jostling, with President Trump contradicting top U.S. health officials regarding timeline and efficacy. The Centers for Disease Control and Prevention say they expect to distribute vaccines publicly at no cost to the patient. But what will the government pay, and how much could drug companies profit? Paul Solman reports.
The full episode is no longer available for online streaming. Why?
Please continue to enjoy extra(s) from this episode.
Problems Playing Video? | Closed Captioning